Early Diagnosis of Gastric Cancer Cachexia

Status Recruiting

Clinical Trial Summary

Gastric cancer is one of the most common malignancies, the morbidity and mortality of which are among the highest. In cancer patients, the incidence of cachexia is very high, and even 80% of patients will eventually develop into cachexia. However, once gastric cancer patients develop cachexia, patients are unlikely to obtain clinically significant benefits from conventional treatment. Therefore, it is important to find biomarkers for early detection of cachexia. The investigators carried out a plasma-derived exosomal microRNA(miRNA) study for early diagnosis of cachexia in gastric cancer, and the development of early diagnosis kits for gastric cancer cachexia.

Clinical Trial Description

Gastric cancer is one of the most common malignancies, the morbidity and mortality of which are among the highest. In gastric cancer patients, the incidence of cachexia is very high, and even 80% of patients will eventually develop into cachexia. However, once gastric cancer patients develop cachexia, patients are unlikely to obtain clinically significant benefits from conventional treatment. Therefore, it is important to find biomarkers for early detection of cachexia. The investigators carried out a plasma-derived exosomal microRNA(miRNA) study for early diagnosis of cachexia in gastric cancer, and the development of early diagnosis kits for gastric cancer cachexia. ;

Study Design

Related Conditions & MeSH terms

Cachexia

Clinical Trial Details

NCT number	NCT06277986
Study type	Observational
Source	Xijing Hospital
Contact	Jipeng Li
Phone	+86-029-84771533
Email	jiangxunliang1992@163.com
Status	Recruiting
Phase
Start date	June 1, 2021
Completion date	September 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05603585` - Optimal Protein Supplementation and Early Exercise In Mechanically Ventilated Patients	N/A
Recruiting	`NCT06206785` - Resting Energy Expenditure in Palliative Cancer Patients
Enrolling by invitation	`NCT05028192` - Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
Completed	`NCT01696604` - A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2849466 in Healthy Male Subjects	Phase 1
Recruiting	`NCT04627376` - Multimodal Program for Cancer Related Cachexia Prevention	N/A
Completed	`NCT02567773` - Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic Study of GSK2881078 and Study to Evaluate the Effect of CYP3A4 Inhibition on PK of GSK2881078	Phase 1
Completed	`NCT00866970` - Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia	Phase 2
Active, not recruiting	`NCT00710632` - Screening to Predict Weight Loss in Patients With Cancer	N/A
Completed	`NCT00031785` - Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer	Phase 3
Withdrawn	`NCT02017925` - Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation	N/A
Recruiting	`NCT01829880` - Impact of Body Composition on Bisoprolol and Ramipril Pharmacokinetics in Patients With Chronic Heart Failure	N/A
Completed	`NCT01419145` - A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study	N/A
Completed	`NCT01692990` - Study on the Effect of Fish Oil and Appetite	Phase 0
Terminated	`NCT00962234` - Metabolism of Lipids in Advanced Cancer	N/A
Terminated	`NCT00851448` - Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients	N/A
Completed	`NCT00994669` - Development of a Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients	N/A
Completed	`NCT01015274` - Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients
Completed	`NCT00972634` - Computerized Questionnaires in Assessing Symptoms, Pain, Depression, and Physical Function in Patients With Metastatic and/or Advanced Locoregional Cancer	N/A
Terminated	`NCT00535015` - Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer	Phase 2
Terminated	`NCT00558558` - Haelan and Nutrition in Cancer Patients	Phase 2